We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High Density Microarrays Profile Noncoding RNAs

By LabMedica International staff writers
Posted on 18 Nov 2008
The first high-density microarray has been launched for the profiling of noncoding ribonucleic acids (RNAs). More...


The NCode human and mouse noncoding RNA microarrays consist of both noncoding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by Invitrogen Corp. (Carlsbad, CA, USA) and then manufactured by Agilent Technologies, Inc. (Santa Clara, CA, USA), using the company's proprietary SurePrint technology. Invitrogen will market and distribute the product.

Transcription, or the synthesis of RNA as directed by DNA, involves not only messenger RNA (mRNA) corresponding to the genes that are translated into proteins, but also tens of thousands of long non-protein-coding RNAs. The noncoding RNAs appear to comprise a vast hidden layer of genetic programming implicated in development and disease pathways in mammals.

"Noncoding RNA transcripts play a variety of roles in a cell, ranging from simple housekeeping to complex regulatory functions, and evidence is mounting that their expression is perturbed in many cancers,” said John Mattick, Ph.D., professor of molecular biology at the University of Queensland (Australia)

"When we talked to scientists about their interest in studying noncoding RNA, many told us they wanted a microarray that consisted of both mRNA and noncoding RNA content, which would help them elucidate the function of specific noncoding RNAs in relation to known pathways of gene expression,” said Amy Butler, vice president of Gene Expression Profiling for Invitrogen. "We answered with an array-based solution, exclusive to Invitrogen that has tens of thousands of coding and noncoding sequences which could answer multiple scientific questions with a single experiment.”

Invitrogen provides products and services that support academic and government institutions, and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition.

Agilent Technologies is a measurement company and a technology leader in communications, electronics, life sciences, and chemical analysis.

Related Links:
Invitrogen
Agilent Technologies
University of Queensland




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.